Description: Sophia Genetics SA, a cloud-based software-as-a-service platform that enables healthcare institutions to get insights from their data. The company offers SOPHiA DDM for solid tumors. Sophia Genetics SA was founded in 2012 and is based in Saint-Sulpice, Switzerland.
Home Page: www.sophiagenetics.com
SOPH Technical Analysis
Rue du Centre 172
Saint-Sulpice,
1025
Switzerland
Phone:
41 21 694 10 60
Officers
| Name | Title |
|---|---|
| Dr. Jurgi Camblong M.B.A., Ph.D. | Co-Founder, CEO & Director |
| Mr. Ross Jordan Muken B.Sc. | Sr. VP & CFO |
| Mr. Abhimanyu Verma | Sr. VP & CTO |
| Dr. Zhenyu Xu Ph.D. | Sr. VP & Chief Scientific Officer |
| Jennifer Pottage | Head of Investor Relations |
| Mr. Daan van Well L.L.M., M.B.A. | Sr. VP, Chief Legal Officer & Gen. Counsel |
| Ms. Manuela Da Silva Valente B.A. | Sr. VP & Chief People Officer |
| Dr. Thierry Colin | Sr. VP of Radiomics Bus. Area |
| Dr. Philippe Menu M.B.A., M.D., Ph.D. | Sr. VP & Chief Medical Officer |
| Ms. Lara Hashimoto | Sr. VP & Chief Bus. Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7017 |
| Price-to-Sales TTM: | 3.3164 |
| IPO Date: | 2021-07-23 |
| Fiscal Year End: | December |
| Full Time Employees: | 518 |